New

Type 2 Diabetes Medication Market

2021

Type 2 Diabetes Medication Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Class (Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, Thiazolidinediones, Alpha-glucosidase Inhibitors, Sulfonylureas and Other Insulin Secretagogues, Biguanides, and SodiumGlucose Cotransporter 2 Inhibitors); Application (Glycemic Control, Cardiovascular Safety, Hypoglycemia Avoidance, and Others), and Geography

| Report Code: TIPRE00024009 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Type 2 Diabetes Medication Market 2028 By Drug Class Inhibitors, Application, and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Type 2 diabetes is a longterm disorder that affects the body's blood sugar level. Elevated blood sugar level (hyperglycemia) causes detrimental effects on the heart, kidneys, eyes, blood vessels, and nerves. Type 2 diabetes is characterized by the resistance of insulin and a relative shortage of insulin. Few common symptoms of type 2 diabetes include increased dehydration, sudden weight loss, and recurrent urination. Type 2 diabetes occurs because of obesity and lack of exercise. It can be prevented partially by eating properly, maintaining a normal weight, and exercising regularly. Type 2 diabetes is generally detected using the glycated hemoglobin test. This blood test indicates the average blood sugar level for the past two to three months. If the patient failed to maintain the target blood sugar level with diet and exercise, the doctor might prescribe diabetes medications that help lower insulin levels or insulin therapy.

MARKET SCOPE

The "Global Type 2 Diabetes Medication Market Analysis to 2028" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Type 2 Diabetes medication market with detailed market segmentation by drug class, application, and geography. The report provides key statistics on the market status of the leading Type 2 Diabetes medication market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

    - Based on drug class, the global Type 2 Diabetes medication market is segmented into dipeptidyl peptidase-4 (dpp-4) inhibitors, glucagon-like peptide-1 (glp-1) receptor agonists, thiazolidinediones, alpha-glucosidase inhibitors, sulfonylureas and other insulin secretagogues, biguanides, sodiumglucose cotransporter 2 inhibitors.
    - On the basis of application, the market is segmented into glycemic control, cardiovascular safety, hypoglycemia avoidance, others.

MARKET DYNAMICS
Drivers:

    - Rise in the incidences of type 2 diabetes.
    - Rise in the support from government in the form of initiatives & programs for type 2 diabetes diagnosis & treatment.
    - Rise in geriatric population.
    - Change in lifestyle.
    - Increasing obesity population.

Restraints:

    - The high cost of diagnosis and treatment therapies for diabetes and the stringent regulations are the major restraining factor for this market.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Type 2 Diabetes medication market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

BThe report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Type 2 Diabetes medication market in these regions.

IMPACT OF COVID-19 ON TYPE 2 DIABETES MEDICATION MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Type 2 Diabetes medication market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Type 2 Diabetes medication market are anticipated to lucrative growth opportunities in the future with the rising demand for Type 2 Diabetes medication in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Type 2 Diabetes medication market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

    - Bayer AG
    - Abbott Laboratories, Inc.
    - GlaxoSmithKline
    - Eli Lilly and Co., PLC
    - Johnson & Johnson Services, Inc.
    - Merck & Co.
    - Pfizer Inc.
    - AstraZeneca, PLC
    - Becton, Dickinson and Co.
    - F. Hoffmann-La Roche Ltd

The Insight Partner's dediType 2 Diabetes medicationed research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Type 2 Diabetes Medication Market - By Drug Class
1.3.2 Type 2 Diabetes Medication Market - By Application
1.3.3 Type 2 Diabetes Medication Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. TYPE 2 DIABETES MEDICATION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. TYPE 2 DIABETES MEDICATION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. TYPE 2 DIABETES MEDICATION MARKET - GLOBAL MARKET ANALYSIS
6.1. TYPE 2 DIABETES MEDICATION - GLOBAL MARKET OVERVIEW
6.2. TYPE 2 DIABETES MEDICATION - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. TYPE 2 DIABETES MEDICATION MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS
7.3.1. Overview
7.3.2. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Forecast and Analysis
7.4. GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS
7.4.1. Overview
7.4.2. Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Market Forecast and Analysis
7.5. THIAZOLIDINEDIONES
7.5.1. Overview
7.5.2. Thiazolidinediones Market Forecast and Analysis
7.6. ALPHA-GLUCOSIDASE INHIBITORS
7.6.1. Overview
7.6.2. Alpha-glucosidase Inhibitors Market Forecast and Analysis
7.7. SULFONYLUREAS AND OTHER INSULIN SECRETAGOGUES
7.7.1. Overview
7.7.2. Sulfonylureas and Other Insulin Secretagogues Market Forecast and Analysis
7.8. BIGUANIDES
7.8.1. Overview
7.8.2. Biguanides Market Forecast and Analysis
7.9. SODIUMGLUCOSE COTRANSPORTER 2 INHIBITORS
7.9.1. Overview
7.9.2. SodiumGlucose Cotransporter 2 Inhibitors Market Forecast and Analysis
8. TYPE 2 DIABETES MEDICATION MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. GLYCEMIC CONTROL
8.3.1. Overview
8.3.2. Glycemic Control Market Forecast and Analysis
8.4. CARDIOVASCULAR SAFETY
8.4.1. Overview
8.4.2. Cardiovascular Safety Market Forecast and Analysis
8.5. HYPOGLYCEMIA AVOIDANCE
8.5.1. Overview
8.5.2. Hypoglycemia Avoidance Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. TYPE 2 DIABETES MEDICATION MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Type 2 Diabetes Medication Market Overview
9.1.2 North America Type 2 Diabetes Medication Market Forecasts and Analysis
9.1.3 North America Type 2 Diabetes Medication Market Forecasts and Analysis - By Drug Class
9.1.4 North America Type 2 Diabetes Medication Market Forecasts and Analysis - By Application
9.1.5 North America Type 2 Diabetes Medication Market Forecasts and Analysis - By Countries
9.1.5.1 United States Type 2 Diabetes Medication Market
9.1.5.1.1 United States Type 2 Diabetes Medication Market by Drug Class
9.1.5.1.2 United States Type 2 Diabetes Medication Market by Application
9.1.5.2 Canada Type 2 Diabetes Medication Market
9.1.5.2.1 Canada Type 2 Diabetes Medication Market by Drug Class
9.1.5.2.2 Canada Type 2 Diabetes Medication Market by Application
9.1.5.3 Mexico Type 2 Diabetes Medication Market
9.1.5.3.1 Mexico Type 2 Diabetes Medication Market by Drug Class
9.1.5.3.2 Mexico Type 2 Diabetes Medication Market by Application
9.2. EUROPE
9.2.1 Europe Type 2 Diabetes Medication Market Overview
9.2.2 Europe Type 2 Diabetes Medication Market Forecasts and Analysis
9.2.3 Europe Type 2 Diabetes Medication Market Forecasts and Analysis - By Drug Class
9.2.4 Europe Type 2 Diabetes Medication Market Forecasts and Analysis - By Application
9.2.5 Europe Type 2 Diabetes Medication Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Type 2 Diabetes Medication Market
9.2.5.1.1 Germany Type 2 Diabetes Medication Market by Drug Class
9.2.5.1.2 Germany Type 2 Diabetes Medication Market by Application
9.2.5.2 France Type 2 Diabetes Medication Market
9.2.5.2.1 France Type 2 Diabetes Medication Market by Drug Class
9.2.5.2.2 France Type 2 Diabetes Medication Market by Application
9.2.5.3 Italy Type 2 Diabetes Medication Market
9.2.5.3.1 Italy Type 2 Diabetes Medication Market by Drug Class
9.2.5.3.2 Italy Type 2 Diabetes Medication Market by Application
9.2.5.4 Spain Type 2 Diabetes Medication Market
9.2.5.4.1 Spain Type 2 Diabetes Medication Market by Drug Class
9.2.5.4.2 Spain Type 2 Diabetes Medication Market by Application
9.2.5.5 United Kingdom Type 2 Diabetes Medication Market
9.2.5.5.1 United Kingdom Type 2 Diabetes Medication Market by Drug Class
9.2.5.5.2 United Kingdom Type 2 Diabetes Medication Market by Application
9.2.5.6 Rest of Europe Type 2 Diabetes Medication Market
9.2.5.6.1 Rest of Europe Type 2 Diabetes Medication Market by Drug Class
9.2.5.6.2 Rest of Europe Type 2 Diabetes Medication Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Type 2 Diabetes Medication Market Overview
9.3.2 Asia-Pacific Type 2 Diabetes Medication Market Forecasts and Analysis
9.3.3 Asia-Pacific Type 2 Diabetes Medication Market Forecasts and Analysis - By Drug Class
9.3.4 Asia-Pacific Type 2 Diabetes Medication Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Type 2 Diabetes Medication Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Type 2 Diabetes Medication Market
9.3.5.1.1 Australia Type 2 Diabetes Medication Market by Drug Class
9.3.5.1.2 Australia Type 2 Diabetes Medication Market by Application
9.3.5.2 China Type 2 Diabetes Medication Market
9.3.5.2.1 China Type 2 Diabetes Medication Market by Drug Class
9.3.5.2.2 China Type 2 Diabetes Medication Market by Application
9.3.5.3 India Type 2 Diabetes Medication Market
9.3.5.3.1 India Type 2 Diabetes Medication Market by Drug Class
9.3.5.3.2 India Type 2 Diabetes Medication Market by Application
9.3.5.4 Japan Type 2 Diabetes Medication Market
9.3.5.4.1 Japan Type 2 Diabetes Medication Market by Drug Class
9.3.5.4.2 Japan Type 2 Diabetes Medication Market by Application
9.3.5.5 South Korea Type 2 Diabetes Medication Market
9.3.5.5.1 South Korea Type 2 Diabetes Medication Market by Drug Class
9.3.5.5.2 South Korea Type 2 Diabetes Medication Market by Application
9.3.5.6 Rest of Asia-Pacific Type 2 Diabetes Medication Market
9.3.5.6.1 Rest of Asia-Pacific Type 2 Diabetes Medication Market by Drug Class
9.3.5.6.2 Rest of Asia-Pacific Type 2 Diabetes Medication Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Type 2 Diabetes Medication Market Overview
9.4.2 Middle East and Africa Type 2 Diabetes Medication Market Forecasts and Analysis
9.4.3 Middle East and Africa Type 2 Diabetes Medication Market Forecasts and Analysis - By Drug Class
9.4.4 Middle East and Africa Type 2 Diabetes Medication Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Type 2 Diabetes Medication Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Type 2 Diabetes Medication Market
9.4.5.1.1 South Africa Type 2 Diabetes Medication Market by Drug Class
9.4.5.1.2 South Africa Type 2 Diabetes Medication Market by Application
9.4.5.2 Saudi Arabia Type 2 Diabetes Medication Market
9.4.5.2.1 Saudi Arabia Type 2 Diabetes Medication Market by Drug Class
9.4.5.2.2 Saudi Arabia Type 2 Diabetes Medication Market by Application
9.4.5.3 U.A.E Type 2 Diabetes Medication Market
9.4.5.3.1 U.A.E Type 2 Diabetes Medication Market by Drug Class
9.4.5.3.2 U.A.E Type 2 Diabetes Medication Market by Application
9.4.5.4 Rest of Middle East and Africa Type 2 Diabetes Medication Market
9.4.5.4.1 Rest of Middle East and Africa Type 2 Diabetes Medication Market by Drug Class
9.4.5.4.2 Rest of Middle East and Africa Type 2 Diabetes Medication Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Type 2 Diabetes Medication Market Overview
9.5.2 South and Central America Type 2 Diabetes Medication Market Forecasts and Analysis
9.5.3 South and Central America Type 2 Diabetes Medication Market Forecasts and Analysis - By Drug Class
9.5.4 South and Central America Type 2 Diabetes Medication Market Forecasts and Analysis - By Application
9.5.5 South and Central America Type 2 Diabetes Medication Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Type 2 Diabetes Medication Market
9.5.5.1.1 Brazil Type 2 Diabetes Medication Market by Drug Class
9.5.5.1.2 Brazil Type 2 Diabetes Medication Market by Application
9.5.5.2 Argentina Type 2 Diabetes Medication Market
9.5.5.2.1 Argentina Type 2 Diabetes Medication Market by Drug Class
9.5.5.2.2 Argentina Type 2 Diabetes Medication Market by Application
9.5.5.3 Rest of South and Central America Type 2 Diabetes Medication Market
9.5.5.3.1 Rest of South and Central America Type 2 Diabetes Medication Market by Drug Class
9.5.5.3.2 Rest of South and Central America Type 2 Diabetes Medication Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL TYPE 2 DIABETES MEDICATION MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. TYPE 2 DIABETES MEDICATION MARKET, KEY COMPANY PROFILES
12.1. BAYER AG
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ABBOTT LABORATORIES, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. GLAXOSMITHKLINE
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ELI LILLY AND CO., PLC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. JOHNSON AND JOHNSON SERVICES, INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MERCK AND CO.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. PFIZER INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. ASTRAZENECA, PLC
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. BECTON, DICKINSON AND CO.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. F. HOFFMANN-LA ROCHE LTD.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Bayer AG
2. Abbott Laboratories, Inc.
3. GlaxoSmithKline
4. Eli Lilly and Co., PLC
5. Johnson & Johnson Services, Inc.
6. Merck & Co.
7. Pfizer Inc.
8. AstraZeneca, PLC
9. Becton, Dickinson and Co.
10. F. Hoffmann-La Roche Ltd.
11. Sanofi Aventis A/S
12. Novo Nordisk
13. Chugai Pharmaceutical Co.
14. Bristol-Myers Squibb
15. Boehringer Ingelheim
16. Takeda
17. Novartis
18. Theracos
19. Lexicon Pharmaceuticals
20. Hua Medicine Shanghai Ltd
21. Tonghua Dongbao Pharmaceutical Co Ltd
22. Jiangsu Hengrui Medicine Co Ltd.
23. Sihuan Pharmaceutical Holdings Group Ltd
24. Biocon Ltd.
25. Oramed Pharamceuticals
TIPRE00024009
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.